Cancer prevention trial comes to a halt

Published: February, 2009

Editor in Chief Marc B. Garnick, M.D., puts the latest findings on selenium and vitamin E into perspective

For men everywhere, the news was disappointing. At the end of October 2008, the National Cancer Institute (NCI) announced that a study designed to test whether selenium and vitamin E, taken alone or in combination, could lower the risk of prostate cancer was ending early; researchers had grown concerned that taking the supplements might do more harm than good. It wasn't the conclusion we were expecting.

To continue reading this article, you must log in.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »